CG
SGNT

Cutler Group’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Cutler Group’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,100
Closed -$16K – 7929
2016
Q2 		$16K Sell
1,100
-200
-15% -$2.57K ﹤0.01% 3649
2016
Q1 		$15K Buy
1,300
+1,000
+333% +$14K ﹤0.01% 3654
2015
Q4 		$4K Buy
+300
New +$4.72K ﹤0.01% 5185

Cutler Group's SGNT Position: Q3 2016 in Review

Cutler Group sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 1,100 shares — an estimated $16K sold.

Cutler Group first reported a position in SGNT in Q4 2015 and held it in 3 quarters. The position peaked at $16K in Q2 2016. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Cutler Group reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Cutler Group sold 1,100 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $16K.
  • Cutler Group first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q4 2015 and held it in 3 quarters.
  • Cutler Group's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $16K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Cutler Group's 13F filing for Q3 2016, filed 11 Oct 2016.